LUPIN LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,633 INR | -4.85% |
|
-1.82% | +23.41% |
| 05-20 | Lupin Gets Six Observations from US FDA After Somerset Unit Inspection | MT |
| 05-13 | Lupin Relaunches Mirabegron ER Tablets in US | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 723B | ||||||
| 595B | ||||||
| 369B | ||||||
| 332B | ||||||
| 282B |
